Shock Management - PowerPoint PPT Presentation

1 / 43
About This Presentation
Title:

Shock Management

Description:

Shock Management Erin Burrell, ACNP-BC Surgical ICU Nurse Practitioner Case study cont.. After initiating milrinone and levophed therapy, Mrs. S improves. – PowerPoint PPT presentation

Number of Views:3432
Avg rating:3.0/5.0
Slides: 44
Provided by: LouisL9
Category:

less

Transcript and Presenter's Notes

Title: Shock Management


1
Shock Management
  • Erin Burrell, ACNP-BC
  • Surgical ICU Nurse Practitioner

2
Objectives
  • Understand the definition of the three different
    types of shock
  • Be able to recognize the different types of shock
    in patient scenarios
  • Understand and apply treatment guidelines for the
    different types of shock

3
What is Shock?
  • Shock is the physiologic state characterized by
    significant reduction of systemic tissue
    perfusion, resulting in decreased tissue oxygen
    delivery.
  • Tissue perfusion is dependent on SVR and CO
  • Imbalance between oxygen delivery and oxygen
    consumption which leads to cell death, end organ
    damage, multi-system organ failure, and death

4
Three Types of Shock
  • Cardiogenic
  • Hypovolemic
  • Distributive
  • Septic
  • Anaphylactic
  • Neurogenic
  • Combined

5
Case Study
  • Mrs. C is a 61yo F who presents to ED complaining
    of fatigue and SOB. She has significant PMHx DM,
    obesity, HTN. Husband also states she has become
    slightly confused.
  • Vitals HR 46, BP 68/32, RR 23, SpO2 95 on RA,
    Afebrile.
  • Labs WBC 8.1, Hgb 12.1, BUN 12, Creat 1.0,
    Troponin 3.1, BG 121.
  • EKG shows ST elevation in II, III, aVF

6
What kind of shock does this patient have?
  1. Cardiogenic
  2. Hypovolemic
  3. Distributive

7
Cardiogenic Shock
  • Shock caused as a result of cardiac pump failure
  • Results in a decrease in CO
  • SVR is increased in an effort to compensate to
    maintain organ perfusion
  • Causes
  • Myocardial Infarction
  • Arrythmias (Atrial fibrillation, ventricular
    tachycardias, bradycardias, etc)
  • Mechanical abnormalities (valvular defects)
  • Extracardiac abnormalities (PE, pulm HTN, tension
    pneumothorax)

8
What information do you have to suggest that Mrs.
C has cardiogenic shock?
  1. Hypotension
  2. Evidence of MI
  3. Altered Mental Status
  4. All of the above
  5. Both A. and B.

9
Treatment of Cardiogenic Shock
  • Correct hypotension
  • Fluid resuscitation to correct hypovolemia
  • Inotropic or Vasopressor support
  • Dobutamine
  • Milrinone
  • Norepinephrine
  • Dopamine
  • Epinephrine
  • Oxygenation
  • If MI ASA, Heparin, and Revascularization
  • If arrthymia correct arrthymia
  • If extracardiac abnormality reverse or treat
    cause

10
Case Study
  • Mr. H is a 18yo M who presents to ED after
    suffering a MCC into a tree. He was unhelmeted
    and has an obvious left femur fx. He was
    intubated for a GCS of 8 in the field and given
    1L NS en route for hypotension.
  • Vitals HR 145, BP 71/38, Intubated with SpO2
    100, Afebrile.
  • Labs WBC 12.3, Hgb 6.7, Plts 72, INR 2.1.
  • Traumagram shows Grade III liver lac.

11
What kind of shock does this patient have?
  1. Cardiogenic
  2. Hypovolemic
  3. Distributive

12
Hypovolemic Shock
  • Shock caused by decreased preload due to
    intravascular volume loss (1/5 of blood volume)
  • Results in decreased CO
  • SVR is typically increased in an effort to
    compensate
  • Causes
  • Hemorrhagic trauma, GI bleed, hemorrhagic
    pancreatitis, fractures
  • Fluid loss induced Diarrhea, vomiting, burns

13
What information do you have to suggest that Mr.
H has hypovolemic shock?
  1. Recent trauma
  2. WBC 12.3
  3. Hgb 6.7
  4. All of the above
  5. Both A. and C.

14
Treatment of Hypovolemic Shock
  • Maximize oxygen delivery
  • Control further blood loss
  • Tourniquets
  • Surgical intervention
  • Fluid resuscitation
  • NS fluid boluses
  • Blood product administration

15
Case Study
  • Mr. S is a 59yo M presents to ED with worsening
    abdominal pain and NV
  • He is POD8 s/p ex-lap, SBR with primary
    anastamosis for chronic SBO at OSH
  • Vitals HR 128, BP 78/45, RR28, SpO2 94 on 4L
    NC, Fever 103.1
  • Labs WBC 20.1, Hgb 9.5, BUN 34, Creat 2.1
  • CT scan of ABD shows anastamotic leak

16
What kind of shock does this patient have?
  1. Cardiogenic
  2. Hypovolemic
  3. Distributive

17
Distributive Shock
  • Shock as a result of severely diminished SVR
  • CO is typically increased in an effort to
    maintain perfusion
  • Subtypes
  • Septic secondary to an overwhelming infection
  • Anaphylactic secondary to a life-threatening
    allergic reaction
  • Neurogenic secondary to a sudden loss of the
    autonomic nervous system function

18
What information do you have to suggest Mr. S has
distributive shock?
  1. SpO2 94 on 4 L NC
  2. Anastamotic leak on CT scan
  3. WBC 20.1
  4. All of the above
  5. Both B. and C.

19
Treatment of Septic Shock
  • Resuscitate
  • 30cc/kg of NS bolus
  • Identify Source
  • Pan cultures
  • CT scan
  • Line removal
  • Foley removal
  • Surgical exploration
  • Antibiotics

20
Treatment of Anaphylactic Shock
  • Remove offending agent
  • Establish an airway and return circulation
  • Pharmacologic support
  • Epinephrine reverses peripheral vasodilation,
    dilates bronchial airways, increases myocardial
    contractility, and suppresses histamine/
    leukotriene release
  • Antihistamine (benadryl) may help counter
    histamine-mediated vasodilation and
    bronchoconstriction
  • Corticosteroids (hydrocortisone) may help
    shorten reaction
  • Bronchodilators

21
Treatment of Neurogenic Shock
  • Establish an airway to maintain adequate
    oxygenation and ventilation
  • Fluid resuscitation for MAPgt65mmHg
  • Inotropic support
  • Dobutamine
  • Dopamine
  • Atropine for severe bradycardia
  • High dose methylprednisolone therapy

22
  • All three types of shock can occur at the same
    time to have a combined shock picture.

23
Case Study
  • Mrs. D is a 71yo F who presented to ED after a 3
    day h/o NV with inability to tolerate PO intake.
    She is now POD0 s/p exlap, pancretectomy for
    necrotizing pancreatitis. She presents to the
    Surgical ICU postop.
  • Vitals HR 121, BP 82/41, Intubated on 100 FiO2,
    Fever 102.8
  • Labs WBC 1.1, Hgb 8.4, BUN 61, Creat 2.82,
    Lactate 3.7

24
Case Study cont..
  • The Surgical ICU team places a MAC with PAC to
    obtain further data about the patients
    hemodynamic status.
  • PAC numbers PAP 18/6, CVP 1, PCWP 2, CI 1.7, SVR
    615

25
What type of shock does this patient have?
  1. Cardiogenic
  2. Hypovolemic
  3. Distributive
  4. All of the Above

26
What information leads you to believe Mrs. D has
a component of cardiogenic shock?
  1. BP 82/41
  2. Temp 102.8
  3. CI 1.7 L/min
  4. Cr 2.82

27
What information demonstrates a component of
hypovolemic shock?
  1. CVP 1 mmHg
  2. PCWP 2 mmHg
  3. SVR 615 dynes/sec/cm-5
  4. PAP 18/6 mmHg
  5. Both A. B. and D.

28
What information indicates a degree of
distributive shock?
  1. PCWP 2 mmHg
  2. SVR 615 dynes/sec/cm-5
  3. PAP 18.16 mmHg
  4. WBC 1.1

29
Mrs. S is suffering from distributive septic
shock along with cardiogenic and hypovolemic
shock.
  1. True
  2. False

30
Case Study cont..
  • The Surgical ICU team starts by giving Mrs. S a
    2L NS bolus and 1L 5 Albumin bolus
  • Vitals HR 114, BP 89/45, Remains intubated on
    SIMV/PRVC 60 FiO2, Febrile 101.7
  • Labs WBC 3.4, Hgb 7.4, BUN 72, Creat 3.21,
    Lactate 2.1
  • Broad spectrum ABX are started immediately upon
    arrival
  • PAC numbers after the initial resuscitation
  • PAP 22/10, CVP 9, PCWP 11, CI 1.5, SVR 682

31
Mrs. S. continues to have a combined shock of
hypovolemic, distributive, and cardiogenic shock.
  1. True
  2. False

32
Mrs. S continues to suffer from cardiogenic and
distributive septic shock as evidence by the
following
  1. CI 1.5 L/min
  2. SVR 682 dynes/sec/cm-5
  3. Both A. and B.

33
As an intensivist, what treatment should be
implemented next?
  1. More fluid resuscitation
  2. Initiate vasopressor support
  3. Initiate inotropic support
  4. No change in current therapy
  5. Both B. and C.

34
Case study cont..
  • After initiating milrinone and levophed therapy,
    Mrs. S improves.
  • Vitals HR 93, BP 122/61, Intubated on PS/CPAP
    40, Afebrile. Levophed at 4mcg/min and Milrinone
    at 0.375mcg/kg/min
  • PA numbers PAP 24/10, CVP 12, PCWP 14, CI 3.6,
    SVR 1120

35
Case study cont..
  • The Surgical ICU team decides to attempt to wean
    vasopressor support first.
  • Mrs. S is successfully weaned off levophed
    support after approximately 12 hours.
  • Vitals HR 87, BP 117/58, Intubated on PS/CPAP
    40, Afebrile. Levophed is off and Milrinone at
    0.375mcg/kg/min
  • PA numbers PAP 22/14, CVP 12, PCWP 14, CI 3.4,
    SVR 1068

36
Case Study cont..
  • After an additional 12 hours, Mrs. S is
    successfully weaned off milrinone support as
    well.
  • She is extubated the next day and progressing
    well.
  • On HOD 6, Mrs. S is complaining of a HA and would
    prefer not to take narcotics.
  • Ibuprofen 200mg q6h PRN is added to HA pain.

37
Case Study cont..
  • After approximately 15 min of her first dose of
    Ibuprofen, Mrs S starts to complain of difficult
    breathing, flushing, and airway edema.
  • The bedside RN notices a new onset of hives
    around Mrs. Ss neck and mouth.
  • Vitals HR 147, BP 54/31, SpO2 91 on 100 NRB,
    Febrile 102.6.

38
What kind of shock is Mrs. S exhibiting?
  1. Cardiogenic
  2. Hypovolemic
  3. Distributive

39
What would you include in your treatment plan?
  1. Benadryl 25 mg IV
  2. Reintubation
  3. Hydrocortisone 100 mg IV
  4. Epinephrine 50 mcg IV
  5. All of the above

40
Case Study cont..
  • Mrs. S is successfully intubated and administered
    treatment for her anaphylaxis. After
    approximately 12hours, her symptoms have
    resolved. She is again extubated and progressing
    well.
  • Mrs. S goes on to rehab and eventually home!

41
Summary
  • Survival and outcomes improve with early
    perfusion, adequate oxygenation, and
    identification with appropriate treatment of the
    cause of shock.

42
  • Questions?

43
References
  • Dellinger, R et al. Surviving Sepsis Campaign
    International Guidelines for Management of Severe
    Sepsis and Septic Shock2012, 41 580-637, 2013.
  • Emergency Medicine. 2009 (Online Accessed on 22
    August 2013) URL http//emergencymed.wordpress.co
    m/2009/03/11/neurogenic-shock/
  • Gaieski et al. 2009 (Online accessed 22 August
    2013) URLhttp//lijhs.sandi.net/faculty/rtenenbau
    m/ap-biology-folder/Links/Shock.utd.pdf
  • Medscape Reference. 1994 (Online accessed 22
    August 2013) URL http//emedicine.medscape.com/ar
    ticle/152191-treatmentshowall
  • Medscape LLC. 2013 (Online access on 22 August
    2013) URL http//emedicine.medscape.com/article/7
    60145-treatment2
  • Soar, J et al. 2013 (Online Accessed on 22 August
    2013) URL http//www.resus.org.uk/pages/reaction.
    pdf
Write a Comment
User Comments (0)
About PowerShow.com